Plant-derived macronutrients are positively associated with higher pregnancy and postpartum human milk oligosaccharides (HMO) in breastmilk and could help mitigate the risk of allergies among infants, according to a study funded by Abbott Nutrition.
Individual human milk oligosaccharides (HMOs) may play critical roles in the maturation of gray matter in an infant brain, showing that inclusion of specific HMOs in infant formula could be beneficial, says a new study.
Chr. Hansen has received regulatory approval to supply a range of Human Milk Oligosaccharides (HMO) to new and existing global markets, following recent endorsements from Australia and New Zealand last year.
A standard milk-based therapy fortified with a specific strain of gut bacteria may reduce inflammation in the infant gut and promote weight gain in infants with severe acute malnutrition, says a new study.
A systematic review of dozens of studies has revealed that levels of the five most prevalent HMOs in breast milk vary widely, and infant formula development should accommodate this variability.
In this series of articles, Alwine Kardinaal, Expertise Group Leader at NIZO, talks to NutraIngredients’ Will Chu about prebiotic human milk oligosaccharides (HMOs) health benefits and applications.
People with irritable bowel syndrome (IBS) may benefit from supplements of human milk oligosaccharides (HMOs), with a new study showing modulation of the gut microbiota, fecal and plasma metabolite profiles.
Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.
Chr. Hansen and Nestlé have settled a legal dispute involving alleged infringements on Human Milk Oligosaccharide (HMO) patents arising from October 2020’s acquisition of Jennewein Biotechnologie.
Supplementation with the human milk oligosaccharides (HMOs) HMOs 2'-fucosyllactose (2'FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.
Levels of two specific human milk oligosaccharides (HMOs) are linked with measure of infant cognitive development, says a pilot study led by R&D Abbott Nutrition.
Probiotic strain specificity is crucial if the benefits of human milk oligosaccharides (HMOs) such as 2′-fucosyllactose are to be passed on to the infant, according to a DuPont-sponsored study.
The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.
Chr. Hansen is to acquire Jennewein Biotechnologie for €310m in a deal designed to merge the bioscience firm’s probiotic interests with the gains Jennewein have made in the Human Milk Oligosaccharides (HMO) market.
Specific strains of probiotic Bifidobacterium and Lactobacillus bacteria given to preterm babies in combination with breast milk may help to build microbial populations and gut health that mirror those of full-term babies, suggests data from the Baby-Associated...
Human milk oligosaccharides (HMOs) may prevent the development of necrotizing enterocolitis (NEC) in premature infants by inhibiting a specific receptor in the intestine linked to inflammation, researchers from Johns Hopkins and Abbott report for the...
Human milk oligosaccharides (HMOs) are the “hot new thing” said an expert recently, as BASF announced the US launch of its 2’-FL (2’-fucosyllactose) ingredient, which is branded Prebilac.
Human milk oligosaccharides (HMOs) have extensive potential to offer a range of health benefits in products beyond infant formula, DuPont's global business director for HMOs, Steen Lyck, said at Vitafoods Asia on Tuesday.
